Cargando…
Molecular biomarkers in cardiac hypertrophy
Cardiac hypertrophy is characterized by an increase in myocyte size in the absence of cell division. This condition is thought to be an adaptive response to cardiac wall stress resulting from the enhanced cardiac afterload. The pathogenesis of heart dysfunction, which is one of the primary causes of...
Autores principales: | Zhu, Liu, Li, Chao, Liu, Qiang, Xu, Weiting, Zhou, Xiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6378174/ https://www.ncbi.nlm.nih.gov/pubmed/30648807 http://dx.doi.org/10.1111/jcmm.14129 |
Ejemplares similares
-
Actin-Binding Proteins in Cardiac Hypertrophy
por: Pan, Congbin, et al.
Publicado: (2022) -
Circular RNAs in the regulation of cardiac hypertrophy
por: Wu, Siyi, et al.
Publicado: (2021) -
Cardiac Hypertrophy: An Introduction to Molecular and Cellular Basis
por: Samak, Mostafa, et al.
Publicado: (2016) -
Noncoding RNAs in Cardiac Hypertrophy and Heart Failure
por: Lu, Peilei, et al.
Publicado: (2022) -
The role and molecular mechanism of FoxO1 in mediating cardiac hypertrophy
por: Yu, Wei, et al.
Publicado: (2020)